Survey on cannabis use in Parkinson's disease:: Subjective improvement of motor symptoms

被引：103

作者：

Venderová, K

Ruzicka, E ^{[1
]}

Vorisek, V

Visnovsky, P

机构：

[1] Charles Univ Prague, Dept Neurol, Movement Disorders Ctr, Fac Med 1, Prague, Czech Republic

[2] Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, CS-50165 Hradec Kralove, Czech Republic

[3] Univ Hosp Hradec, Dept Biochem, Div Clin Toxicol & Mass Spectrometry, Kralove, Czech Republic

来源：

MOVEMENT DISORDERS | 2004年 / 19卷 / 09期

关键词：

cannabis; Parkinson's disease; cannabinoid;

D O I：

10.1002/mds.20111

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit. (C) 2004 Movement Disorder Society.

引用

页码：1102 / 1106

页数：5

共 32 条

[1] Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
Bisogno, T
Hanus, L
De Petrocellis, L
Tchilibon, S
Ponde, DE
Brandi, I
Moriello, AS
Davis, JB
Mechoulam, R
Di Marzo, V
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) : 845 - 852
[2] Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
Bisogno, T
Sepe, N
Melck, D
Maurelli, S
DePetrocellis, L
DiMarzo, V
[J]. BIOCHEMICAL JOURNAL, 1997, 322 : 671 - 677
[3] BORNHEIM LM, 1995, DRUG METAB DISPOS, V23, P825
[4] CB1 cannabinoid receptor signalling in Parkinson's disease
Brotchie, JM
[J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) : 54 - 61
[5] Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
Brotchie, JM
[J]. MOVEMENT DISORDERS, 1998, 13 (06) : 871 - 876
[6] BROTCHIE JM, 1997, BRIT J PHARMACOL, V123, P67
[7] The perceived effects of smoked cannabis on patients with multiple sclerosis
Consroe, P
Musty, R
Rein, J
Tillery, W
Pertwee, R
[J]. EUROPEAN NEUROLOGY, 1997, 38 (01) : 44 - 48
[8] Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
Di Marzo, V
Hill, MP
Bisogno, T
Crossman, AR
Brotchie, JM
[J]. FASEB JOURNAL, 2000, 14 (10) : 1432 - 1438
[9] INHIBITION OF THE CATALEPTIC EFFECT OF TETRAHYDROCANNABINOL BY OTHER CONSTITUENTS OF CANNABIS-SATIVA L
FORMUKONG, EA
EVANS, FJ
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (02) : 132 - 134
[10] Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
Fox, SH
Henry, B
Hill, M
Crossman, A
Brotchie, J
[J]. MOVEMENT DISORDERS, 2002, 17 (06) : 1180 - 1187

← 1 2 3 4 →